BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

New Study Describes Novel Chemical Modifications to Fluorescent Dyes for Improved Super-Resolution Imaging by STORM

Biotium, a leading life science reagent supplier and producer of innovative dyes, has collaborated with Professor Ke Xu at University of California, Berkel...

January 28, 2022 | News

Harbour Group's SpotSee Acquires the Assets of Biosynergy

Biosynergy manufactures and distributes temperature indicators used in the life sciences market, primarily in monitoring temperature on blood bags. M...

January 25, 2022 | News

Liminal BioSciences Announces Strategic Priorities for 2022

"2021 has been an important year for us: we have simplified our business strategy and created a liquidity reserve that will allow us to focus our resources...

January 24, 2022 | News

Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings

Clinical Stage Asset Has Potential for First Approved Oral Therapy for Leber's Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP) Caused by Mutatio...

January 20, 2022 | News

Australia (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

January 20, 2022 | News

Dermaliq Therapeutics to Transform Drug Therapies into Clinical Trials

- Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq - Spin-off to unlock value in the space of medical der...

January 19, 2022 | News

Seegene Unveils Blueprint for the Future of Molecular Diagnostics

Along with three solutions, he also introduced the company's automated, AI-enabled platform with a standard development tool that will empower users to eas...

January 13, 2022 | News

Illumina collaborates with Nashville Biosciences to accelerate medicines development

Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC)...

January 11, 2022 | News

Hansa intends to explore allogeneic hematopoietic stem cell transplantation (HSCT)

As part of Hansa Biopharma's platform strategy and objective to broaden the application of imlifidase as a potential therapy to change the course of Ig...

January 10, 2022 | News

Singapore scientists awarded Wellcome Leap R3 contract to develop mRNA technology

A team of researchers from A*STAR’s Genome Institute of Singapore (GIS) and Institute of Bioengineering and Bioimaging (IBB), together with the Natio...

January 07, 2022 | News

Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems

PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will i...

January 07, 2022 | News

Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

Under this agreement, ProBioGen develops a scalable process and granted Imvaq® a license to use ProBioGen's AGE1.CR.pIX cell line for the man...

January 07, 2022 | News

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and othe...

January 05, 2022 | News

Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002

A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D Center, and another team of scientists from SIMM of CAS, led by P...

January 04, 2022 | News

Stay Connected